DiPalma Stephen J. 4
4 · RXI PHARMACEUTICALS CORP · Filed Jan 20, 2009
Insider Transaction Report
Form 4
DiPalma Stephen J.
CFO, EVP, Secretary
Transactions
- Award
Stock Option
2009-01-15+47,000→ 166,428 totalExercise: $4.19Exp: 2019-01-15→ Common Stock (47,000 underlying) - Award
Stock Option
2009-01-15+36,218→ 202,646 totalExercise: $4.19Exp: 2019-01-15→ Common Stock (36,218 underlying)
Footnotes (4)
- [F1]Granted pursuant to the RXi Pharmaceuticals Corporation 2007 Incentive Plan.
- [F2]Per share.
- [F3]The options vest in the following increments on the following dates: 2,937 shares on April 15, 2009, 2,938 shares on July 15, 2009, 2,937 shares on October 15, 2009, 2,938 on January 15, 2010, 2,937 shares on April 15, 2010, 2,938 shares on July 15, 2010, 2,937 shares on October 15, 2010, 2,938 on January 15, 2011, 2,937 shares on April 15, 2011, 2,938 shares on July 15, 2011, 2,937 shares on October 15, 2011, 2,938 on January 15, 2012, 2,937 shares on April 15, 2012, 2,938 shares on July 15, 2012, 2,937 shares on October 15, 2012, and 2,938 on January 15, 2013, so that all of the options will be fully vested on January 15, 2013.
- [F4]The options vest in the following increments on the following dates: 2,263 shares on April 15, 2009, 2,264 shares on July 15, 2009, 2,263 shares on October 15, 2009, 2,264 on January 15, 2010, 2,264 shares on April 15, 2010, 2,263 shares on July 15, 2010, 2,264 shares on October 15, 2010, 2,264 on January 15, 2011, 2,263 shares on April 15, 2011, 2,264 shares on July 15, 2011, 2,263 shares on October 15, 2011, 2,264 on January 15, 2012, 2,264 shares on April 15, 2012, 2,263 shares on July 15, 2012, 2,264 shares on October 15, 2012, and 2,264 on January 15, 2013, so that all of the options will be fully vested on January 15, 2013.